Patents by Inventor Rainer Walter

Rainer Walter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7965665
    Abstract: In a UMTS wireless communication system a UE autonomously determines that it is going to transit from an active traffic mode into an idle traffic mode and informs the NodeBs in its active set that it is doing so. It does so either by using Layer 1 signaling, using the uplink DPCCH to send a message to the NodeBs indicating the transition, or by using Layer 2 signaling by via MAC PDUs that contain the message, which are delivered on the uplink E-DPDCH to the NodeBs.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: June 21, 2011
    Assignee: Alcatel-Lucent USA Inc.
    Inventors: Rainer Walter Bachl, Anil M Rao, Mirko Schacht
  • Patent number: 7940721
    Abstract: An exemplary method of controlling communications that may include enhanced dedicated channel (E-DCH) traffic includes setting a total uplink power limit below an allowable power limit. A minimum amount of uplink resources is allocated to each user requesting E-DCH service on an individual user basis such that a cumulative E-DCH power allocation satisfies a selected minimum E-DCH power allocation threshold. A determination whether to grant a non-E-DCH service request is made based upon a relationship between the current total uplink power and the total uplink power limit and a relationship between the selected minimum E-DCH power allocation threshold and a current cumulative E-DCH power.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: May 10, 2011
    Assignee: Alcatel-Lucent USA Inc.
    Inventors: Rainer Walter Bachl, Jens Mueckenheim, Enrico Jugl
  • Publication number: 20110098282
    Abstract: Novel compounds of which the following is exemplary:
    Type: Application
    Filed: August 12, 2008
    Publication date: April 28, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Norbert Hauel, Angelo Ceci, Henri Doods, Iris Kauffmann-Hefner, Ingo Konetzki, Annette Schuler-Metz, Rainer Walter
  • Patent number: 7929962
    Abstract: A method is provided for maintaining synchronization between an AT and a base station during an idle period. During the idle period, a reduced number of uplink reference signals for uplink channel quality estimation are sent to the base station by the AT. The uplink reference signals are sent to assist coherent demodulation and uplink channel quality estimation for scheduling. During the uplink idle period, the numbers of uplink reference signals are designed to be reduced in selective coherent bandwidths. The selection of the coherent bandwidth alternates in time and covers the entire spectrum to allow the channel quality estimation through the entire spectrum.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: April 19, 2011
    Assignee: Alcatel-Lucent USA Inc.
    Inventors: Rainer Walter Bachl, Fang-Chen Cheng, Lei Song
  • Publication number: 20110046106
    Abstract: The present invention relates to compounds of general formula I wherein A, B, R1, R2 and R3 are defined as in claim 1, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.
    Type: Application
    Filed: February 5, 2009
    Publication date: February 24, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Norbert Hauel, Angelo Ceci, Henri Doods, Iris Kauffmann-Hefner, Ingo Konetzki, Annette Schuler-Metz, Rainer Walter
  • Publication number: 20110021488
    Abstract: The present invention relates to compounds of general formula I wherein A, B, D, Y, R1, R2, R3, R4 and R5 are defined as in the specification, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.
    Type: Application
    Filed: October 5, 2010
    Publication date: January 27, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Iris KAUFFMANN-HEFNER, Norbert HAUEL, Rainer WALTER, Heiner EBEL, Henri DOODS, Angelo CECI, Annette SCHULER-METZ, Ingo KONETZKI
  • Patent number: 7858618
    Abstract: The present invention relates to compounds of general formula I wherein A, B, D, Y, R1, R2, R3, R4 and R5 are defined as in the specification, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: December 28, 2010
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Iris Kauffmann-Hefner, Norbert Hauel, Rainer Walter, Heiner Ebel, Henri Doods, Angelo Ceci, Annette Schuler-Metz, Ingo Konetzki
  • Publication number: 20100240669
    Abstract: The present invention relates to the compounds of general formula I wherein n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and X are defined as described hereinafter, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the medicaments containing the pharmacologically effective compounds, the preparation thereof and the use thereof.
    Type: Application
    Filed: February 24, 2010
    Publication date: September 23, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Norbert HAUEL, Angelo CECI, Henri DOODS, Ingo KONETZKI, Juergen MACK, Henning PRIEPKE, Annette SCHULER-METZ, Rainer WALTER, Dieter WIEDENMAYER
  • Patent number: 7782900
    Abstract: A method is provided for operating a multi-bandwidth OFDMA system that can achieve an enhanced bandwidth efficiency due to windowing without significantly impacting the underlying physical design of the receive filters. The method comprises establishing a bandwidth over which the radio resources transmit signals, the bandwidth being comprised of an edge-band and a center-band. Narrow band radio resources are assigned to a portion of the bandwidth that is at least partially within the edge-band.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: August 24, 2010
    Assignee: Alcatel-Lucent USA Inc.
    Inventors: Rainer Walter Bachl, Fang-Chen Cheng, James Paul Seymour, Lei Song, Said Tatesh
  • Publication number: 20100197664
    Abstract: Disclosed are compounds of the formula I wherein A, Y, R1, R2, R3, R4 and R5 are defined, suitable for treating diseases and symptoms of diseases caused at least to some extent by stimulation of bradykinin-B1 receptors, the preparation thereof and the use thereof.
    Type: Application
    Filed: July 23, 2008
    Publication date: August 5, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Iris Kauffmann-Hefner, Angelo Ceci, Henri Doods, Norbert Hauel, Ingo Konetzki, Annette Schuler-Metz, Rainer Walter
  • Publication number: 20100190767
    Abstract: Compounds of formula 1 and hetero derivatives thereof and the pharmacologically acceptable salts, enantiomers, racemates, hydrates, or solvates thereof, which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.
    Type: Application
    Filed: April 2, 2010
    Publication date: July 29, 2010
    Inventors: Ralf ANDERSKEWITZ, Horst Dollinger, Rolf Goeggel, Birgit Jung, Joerg Kley, Juergen Mack, Peter Nickolaus, Rainer Walter
  • Patent number: 7754756
    Abstract: The present invention relates to new beta-agonists of general formula (I) wherein the groups R1 and R2 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers, solvates, hydrates, mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, methods of preparing these compounds and their use as pharmaceutical compositions.
    Type: Grant
    Filed: October 19, 2006
    Date of Patent: July 13, 2010
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rainer Walter, Bradford S. Hamilton, Thomas Trieselmann, Matthew R. Netherton, Marco Santagostino, Ingo Konetzki
  • Patent number: 7723381
    Abstract: Compounds of formula 1 and hetero derivatives thereof and the pharmacologically acceptable salts, enantiomers, racemates, hydrates, or solvates thereof, which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin, or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: May 25, 2010
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Ralf Anderskewitz, Horst Dollinger, Rolf Goeggel, Birgit Jung, Joerg Kley, Juergen Mack, Peter Nickolaus, Rainer Walter
  • Patent number: 7715349
    Abstract: In a 3GPP standards Release 6 UMTS system, in order to avoid searching at NodeB for a maximum E-DPCCH-associated metric at discrete possible valid index values, or over disjoint possible valid index regions, at the UE the three different sources of information, the fixed number bits that comprise the RSN, TFI and the H-bit components of the E-DPCCH bit field, are mapped so that the decimal equivalents of the possible E-DPCCH indices lie within a continuous range of values.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: May 11, 2010
    Assignee: Alcatel-Lucent USA Inc.
    Inventors: Rainer Walter Bachl, Florian Derriennic, Francis Dominique, Hongwei Kong, Said Tatesh
  • Publication number: 20100040155
    Abstract: A MIMO transmission scheme is provided which provides some advantages of the Alamouti code but which can be adapted so as to provide enhanced performance for a given amount of antenna correlation. A block of complex scalar input symbols is mapped to a block-code matrix which is transmitted as a spacetime signal matrix from an array of two or more antennas. The block-code matrix is assembled by combining input data with specified dispersion matrices. Each of the dispersion matrices is determined, in part, by an adjustable parameter which relates to a degree of beam-forming behavior by the transmission antenna array.
    Type: Application
    Filed: August 14, 2008
    Publication date: February 18, 2010
    Inventors: Rainer Walter Bachl, Peter Christian Gunreben
  • Patent number: 7664467
    Abstract: A method for coordinating control of radio resources for multicast/broadcast services in distributed radio resource management. The method includes communicating information between a plurality of units having radio resource management responsibilities. The communicated information is related to coordinating at least one multicast/broadcast service provided by the plurality of units.
    Type: Grant
    Filed: June 19, 2006
    Date of Patent: February 16, 2010
    Assignee: Alcatel-Lucent USA Inc.
    Inventors: Fang-Chen Cheng, Sudeep Palat, Rainer Walter Bachl
  • Publication number: 20090306104
    Abstract: The invention relates to a method of treating immunologic diseases or pathological conditions involving an immunologic component using certain Lck inhibitors already known as kinase inhibitors for therapy in oncology, optionally in combination with one or more other drugs selected from NSAIDs, steroids, DMARDs, immunsuppressives, biologic response modifiers and antinfectives, pharmaceutical compositions comprising said Lck inhibitors together with said other drugs, and the use of the Lck inhibitors for the manufacture of a pharmaceutical composition for the treatment of immunologic diseases or pathological conditions involving an immunologic component.
    Type: Application
    Filed: August 16, 2009
    Publication date: December 10, 2009
    Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
    Inventors: Gerald Juergen Roth, Armin Heckel, Rainer Walter, Frank Hilberg, Rudolf Hauptmann, Martin Fredrich Stefanic, Florian Colbatzky, Steffan Ernest
  • Publication number: 20090137545
    Abstract: The present invention relates to compounds of general formula I wherein A, B, D, Y, R1, R2, R3, R4 and R5 are defined as in the specification, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.
    Type: Application
    Filed: August 17, 2007
    Publication date: May 28, 2009
    Inventors: Iris Kauffmann-Hefner, Norbert Hauel, Rainer Walter, Heiner Ebel, Henri Doods, Angelo Ceci, Annette Schuler-Metz, Ingo Konetzki
  • Patent number: 7526304
    Abstract: In a UMTS wireless communication system, the enhanced dedicated physical control channel (E-DPCCH) that is usually always transmitted together with the enhanced dedicated physical data channel (E-DPDCH) on the uplink from a UE to a NodeB is instead only transmitted when a predetermined “start criterion” is met and is turned off when a predetermined “stop criterion” is met until a “start criterion” is later met again. The UE starts transmitting E-DPCCH whenever the corresponding E-DPDCH transport format combination is different from the previous one in the same HARQ process or some other “start criterion” is met. Multiple mechanisms can be used to decide when the UE should switch off E-DPCCH transmission after the transport format combination of E-DPDCH has changed.
    Type: Grant
    Filed: September 29, 2005
    Date of Patent: April 28, 2009
    Assignee: Alcatel-Lucent USA Inc.
    Inventors: Rainer Walter Bachl, Anil M Rao, Mirko Schacht, Henry Hui Ye
  • Patent number: 7522682
    Abstract: The present invention provides a method and an apparatus for measuring a reception quality on a wireless communication link to a receiver by removing a bias in a plurality of received pilot symbols and obtaining a channel estimate for a channel, such as a wireless propagation channel, after substantially removing the bias. For a receiver, such as a rake receiver disposed in a base transceiver station, a bias removal module may extract a plurality of coefficients from a wireless propagation channel to remove a bias before a detector may receive the plurality of pilot symbols in the data stream to determine an error rate of the received pilot symbols where channel estimation is based on the received pilot symbols. In this manner, a systematic flaw in a link quality measurement based on an error rate of the received pilot symbols may be resolved for wireless communication systems.
    Type: Grant
    Filed: December 29, 2004
    Date of Patent: April 21, 2009
    Assignee: Alcatel-Lucent USA Inc.
    Inventors: Frank Gerhard Ernst Obernosterer, Peter Christian Gunreben, Rainer Walter Bachl